ADRENALIN TOPICAL SOLUTION 1 MG
EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG · DIN 00155365 · SEARCHLIGHT PHARMA INC
Health Canada status: MARKETED
What is ADRENALIN TOPICAL SOLUTION?
ADRENALIN TOPICAL SOLUTION 1 MG contains EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00155365, held by SEARCHLIGHT PHARMA INC, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as marketed, status dated 06-Oct-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ADRENALIN TOPICAL SOLUTION used for?
Hemostatic agent in mucosal and sinus surgery, such as endonasal surgeries and endodontic mini-surgeries when reduction of local hemorrhage is indicated.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00155365 |
|---|---|
| Brand name | ADRENALIN TOPICAL SOLUTION |
| Generic / active ingredient | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG |
| Manufacturer | SEARCHLIGHT PHARMA INC |
| Strength | 1 MG |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | B02BC09 EPINEPHRINE |
| AHFS class | 52:32.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Oct-2022 |
| Original market date | 1951-12-31 00:00:00 |
How is it administered?
For topical use only. Apply 1 mg/mL solution locally with a sterile swab as required. Do not inject. Remove metal ferrule and rubber stopper to pour out solution.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Protect from light and freezing. Store at room temperature between 15 °C and 30 °C. Do not remove from carton until ready to use.
How is it supplied?
Vials of 30 mL with a removable tear-off metal ferrule and rubber stopper.
Contraindications
Narrow angle glaucoma, shock during general anesthesia with halogenated hydrocarbons, organic brain damage, local anesthesia of fingers/toes, labour, cardiac dilatation, coronary insufficiency.
Warnings and precautions
DO NOT INJECT. Inadvertent injection can result in cardiac arrest and death. Use caution in elderly, cardiovascular disease, hypertension, diabetes, hyperthyroidism, or asthma. Contains sulfites.
Is EPINEPHRINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.